Skip to main content

and
  1. No Access

    Article

    Lipid-Modulating Treatments for Mixed Dyslipidemia Increase HDL-Associated Phospholipase A2 Activity with Differential Effects on HDL Subfractions

    The effect of lipid-modulating treatments on modification of high density lipoprotein (HDL) subfractions remains unknown. In this study, mixed dyslipidemia patients (n = 100) inadequately controlled with a standa...

    Anastazia Kei, Evangelos Liberopoulos, Costantinos Tellis, Moses Elisaf in Lipids (2013)

  2. No Access

    Article

    Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative Stress

    Ezetimibe effectively reduces low-density lipoprotein cholesterol (LDL-C). In this study, we tested the hypothesis that ezetimibe monotherapy may also decrease markers of oxidative stress in subjects with hype...

    Michael S. Kostapanos, Athanasia T. Spyrou, Constantinos C. Tellis, Irene F. Gazi in Lipids (2011)

  3. No Access

    Article

    Plasma Lipoproteins and Triacylglycerol are Predictors of Small, Dense LDL Particles

    Recently published data suggest that the assessment of LDL subfraction profiles may contribute to the determination of the cardiovascular risk. In this study, we tested the ability of various metabolic paramet...

    Vasilis Tsimihodimos, Irene Gazi, Christina Kostara, Alexandros D. Tselepis in Lipids (2007)

  4. No Access

    Article

    The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol

    The hypertriglyceridemic waist (HTGW) phenotype (hypertriglyceridemia and increased waist circumference) has been proposed as an inexpensive tool to monitor individuals with the atherogenic metabolic triad, hy...

    Irene F. Gazi, Theodosios D. Filippatos, Vasilis Tsimihodimos in Lipids (2006)

  5. Article

    Open Access

    LDL cholesterol estimation in patients with the metabolic syndrome

    The Friedewald formula (LDL-F) for the estimation of low-density lipoprotein (LDL) cholesterol concentrations is the most often used formula in clinical trials and clinical practice. However, much concern has ...

    Irene Gazi, Vasilis Tsimihodimos, Theodosios D Filippatos in Lipids in Health and Disease (2006)